<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about FBT</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Tue, 18 Jun 2013 22:27:16 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=FBT" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/3-impressive-biotech-etfs-crushing-the-market-etf-news-and-commentary-cm252203">
      <guid isPermaLink="false">252203</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y6PVCz1NpK8/3-impressive-biotech-etfs-crushing-the-market-etf-news-and-commentary-cm252203</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>3 Impressive Biotech ETFs Crushing the Market - ETF News And Commentary</title>
      <description>While the markets continue to do quite well, many investors have seen some sector rotation starting to take place. The move as of late has been out of lower risk, high dividend, sectors like&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Y6PVCz1NpK8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 11 Jun 2013 17:26:44 Z</pubDate>
      <a10:updated>2013-06-11T14:31:12Z</a10:updated>
      <author>Eric Dutram</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/3-impressive-biotech-etfs-crushing-the-market-etf-news-and-commentary-cm252203</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/biotechnology-etf-investing-101-etf-news-and-commentary-cm247227">
      <guid isPermaLink="false">247227</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5o9xQM76YTQ/biotechnology-etf-investing-101-etf-news-and-commentary-cm247227</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Biotechnology ETF Investing 101 - ETF News And Commentary</title>
      <description>With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/5o9xQM76YTQ" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 20 May 2013 19:03:46 Z</pubDate>
      <a10:updated>2013-05-20T16:07:14Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/biotechnology-etf-investing-101-etf-news-and-commentary-cm247227</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bestworst-daily-etf-returns-biotech-up-cm245531">
      <guid isPermaLink="false">245531</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QWTE2MVaOGE/bestworst-daily-etf-returns-biotech-up-cm245531</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Best/Worst Daily ETF Returns: Biotech Up</title>
      <description>The Guggenheim Solar fund (NYSEArca:TAN) spiked 6.58 percent on Friday, May 10, while markets rallied, with the S&amp;amp;P 500 rising 7.03 points, or 0.43 percent, to close at 1,633.70.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/QWTE2MVaOGE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 17:14:32 Z</pubDate>
      <a10:updated>2013-05-13T16:14:35Z</a10:updated>
      <author>Hannah Tool</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GEX</nasdaq:tickers>
      <nasdaq:tickers>PBW</nasdaq:tickers>
      <nasdaq:tickers>QCLN</nasdaq:tickers>
      <nasdaq:tickers>TAN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bestworst-daily-etf-returns-biotech-up-cm245531</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485">
      <guid isPermaLink="false">245485</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/reFOOhXCKA0/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013</title>
      <description>Amgen Inc. (  AMGN  ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/reFOOhXCKA0" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 15:39:06 Z</pubDate>
      <a10:updated>2013-05-13T13:21:43Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PJP</nasdaq:tickers>
      <nasdaq:tickers>XLV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amgen-inc-amgn-exdividend-date-scheduled-for-may-14-2013-cm245485</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/is-the-biotech-sector-still-a-market-leader-real-time-insight-cm240666">
      <guid isPermaLink="false">240666</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xlmqy0DjgsE/is-the-biotech-sector-still-a-market-leader-real-time-insight-cm240666</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Is the Biotech Sector Still a Market Leader? - Real Time Insight</title>
      <description>The biotechnology sector has been a strong performer for much of  2013. The space has seen huge gains over and above that of the  broad market, with biotech benchmarks outpacing the S&amp;amp;P&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Xlmqy0DjgsE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 25 Apr 2013 19:18:48 Z</pubDate>
      <a10:updated>2013-04-25T15:19:03Z</a10:updated>
      <author>Eric Dutram</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/is-the-biotech-sector-still-a-market-leader-real-time-insight-cm240666</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bestworst-daily-etf-returns-biotech-rises-cm239036">
      <guid isPermaLink="false">239036</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V9LJmvpUaGI/bestworst-daily-etf-returns-biotech-rises-cm239036</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Best/Worst Daily ETF Returns: Biotech Rises</title>
      <description>The First Trust NYSE Arca Biotechnology fund (NYSEArca:FBT) added 5.96 percent on Friday, April 19, leading a handful of other biotech funds as the S&amp;amp;P 500 rose 13.64 points, or 0.88&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/V9LJmvpUaGI" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 22 Apr 2013 17:09:17 Z</pubDate>
      <a10:updated>2013-04-23T01:09:31Z</a10:updated>
      <author>Hannah Tool</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bestworst-daily-etf-returns-biotech-rises-cm239036</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/vertex-news-lifts-biotech-etfs-cm238680">
      <guid isPermaLink="false">238680</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rrx792_12jo/vertex-news-lifts-biotech-etfs-cm238680</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>Vertex News Lifts Biotech ETFs</title>
      <description>Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ:  VRTX  ) are soaring by more than 55 percent early Friday and have touched a new all-time high after the company announced late&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rrx792_12jo" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 19 Apr 2013 18:52:13 Z</pubDate>
      <a10:updated>2013-04-22T20:17:07Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/vertex-news-lifts-biotech-etfs-cm238680</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/under-the-hood-an-unheralded-biotech-etf-cm236052">
      <guid isPermaLink="false">236052</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJRWlq0rWpM/under-the-hood-an-unheralded-biotech-etf-cm236052</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>Under The Hood: An Unheralded Biotech ETF</title>
      <description>Another day, another set of fresh all-time highs for the major biotechnology  ETFs  . Biotech investors were treated to the  same feat in late March  , but as health care has continued to be a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sJRWlq0rWpM" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 11 Apr 2013 21:53:01 Z</pubDate>
      <a10:updated>2013-04-15T11:38:32Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/under-the-hood-an-unheralded-biotech-etf-cm236052</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/tech-biotech-etfs-lead-markets-jump-to-new-highs-cm235702">
      <guid isPermaLink="false">235702</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wjw5fuf0ixo/tech-biotech-etfs-lead-markets-jump-to-new-highs-cm235702</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Tech, Biotech ETFs Lead Market's Jump To New Highs</title>
      <description>Technology and biotech  ETFs  fronted the U.S. stock market's rally to a historic high Wednesday as the Federal Reserve minutes, released five hours early, showed Fed officials agreed that the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wjw5fuf0ixo" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 11 Apr 2013 03:32:00 Z</pubDate>
      <a10:updated>2013-04-11T01:06:44Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>IGN</nasdaq:tickers>
      <nasdaq:tickers>JDSU</nasdaq:tickers>
      <nasdaq:tickers>JNPR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/tech-biotech-etfs-lead-markets-jump-to-new-highs-cm235702</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/biotech-breakout-boosting-etfs-cm231913">
      <guid isPermaLink="false">231913</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jc8e3MCR2BQ/biotech-breakout-boosting-etfs-cm231913</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>Biotech Breakout Boosting ETFs</title>
      <description>The four horsemen of the biotechnology - Amgen (NASDAQ:  AMGN  ), Biogen Idec (NASDAQ:  BIIB  ), Celgene (NASDAQ:  CELG  ) and Gilead Sciences (NASDAQ:  GILD  ) - all hit new 52-week highs&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Jc8e3MCR2BQ" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 28 Mar 2013 23:21:50 Z</pubDate>
      <a10:updated>2013-04-02T18:49:49Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>AMGN</nasdaq:tickers>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>BIIB</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/biotech-breakout-boosting-etfs-cm231913</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810">
      <guid isPermaLink="false">225810</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VsjBhwR-GMU/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Gilead Puts Biotech ETFs in Focus - ETF News And Commentary</title>
      <description>California-based Gilead Sciences (  GILD  ) was in focus last week as it saw some encouraging clinical trial data on its HIV pill-TAF. This report pushed up GILD by about 4.5% last week and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/VsjBhwR-GMU" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Mar 2013 19:10:39 Z</pubDate>
      <a10:updated>2013-03-11T16:13:43Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BBH</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>GILD</nasdaq:tickers>
      <nasdaq:tickers>IBB</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gilead-puts-biotech-etfs-in-focus-etf-news-and-commentary-cm225810</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/a-look-ahead-this-weeks-etfs-to-watch-cm225340">
      <guid isPermaLink="false">225340</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nAtXbBNTyqE/a-look-ahead-this-weeks-etfs-to-watch-cm225340</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>Investing Ideas</category>
      <title>A Look Ahead: This Week's ETFs to Watch</title>
      <description>Stocks just keep on chugging higher. Buoyed by a surprisingly strong February jobs report, the S&amp;amp;P 500 and the Dow Jones Industrial each gained about half a percent last Friday.  For&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/nAtXbBNTyqE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 11 Mar 2013 15:12:13 Z</pubDate>
      <a10:updated>2013-03-13T11:40:33Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>EEM</nasdaq:tickers>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>PIE</nasdaq:tickers>
      <nasdaq:tickers>UYG</nasdaq:tickers>
      <nasdaq:tickers>XLF</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/a-look-ahead-this-weeks-etfs-to-watch-cm225340</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/if-stocks-keep-soaring-get-to-know-these-leveraged-etfs-cm225094">
      <guid isPermaLink="false">225094</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7JvyRljGtE/if-stocks-keep-soaring-get-to-know-these-leveraged-etfs-cm225094</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>International</category>
      <category>Investing Ideas</category>
      <title>If Stocks Keep Soaring, Get to Know These Leveraged ETFs</title>
      <description>Another day, another intrday record for the Dow Jones Industrial Average. Buoyed by a stronger-than-expected February jobs report, U.S. stocks continue to grind higher.  Friday's action is of&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/x7JvyRljGtE" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 09 Mar 2013 00:16:13 Z</pubDate>
      <a10:updated>2013-03-12T18:54:03Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>IYF</nasdaq:tickers>
      <nasdaq:tickers>SPY</nasdaq:tickers>
      <nasdaq:tickers>UYG</nasdaq:tickers>
      <nasdaq:tickers>XBI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/if-stocks-keep-soaring-get-to-know-these-leveraged-etfs-cm225094</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/two-sector-etfs-to-buy-in-2013-etf-news-and-commentary-cm206800">
      <guid isPermaLink="false">206800</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wZuk026Krkk/two-sector-etfs-to-buy-in-2013-etf-news-and-commentary-cm206800</link>
      <category>Investing</category>
      <category>ETFs</category>
      <title>Two Sector ETFs to Buy in 2013 - ETF News And Commentary</title>
      <description>In the current uncertain economic environment with ultra low interest rates, investors have been starved for income in 2012. Investors in search of a decent level of current income have&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wZuk026Krkk" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 11 Jan 2013 23:35:01 Z</pubDate>
      <a10:updated>2013-01-11T20:17:14Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>ITB</nasdaq:tickers>
      <nasdaq:tickers>XHB</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/two-sector-etfs-to-buy-in-2013-etf-news-and-commentary-cm206800</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/4-health-care-etfs-your-broker-forgot-to-mention-cm204852">
      <guid isPermaLink="false">204852</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6C4S2Bk-Fo/4-health-care-etfs-your-broker-forgot-to-mention-cm204852</link>
      <category>Investing</category>
      <category>ETFs</category>
      <category>International</category>
      <category>Investing Ideas</category>
      <title>4 Health Care ETFs Your Broker Forgot to Mention</title>
      <description>When it comes to health care  ETFs  , there are plenty for investors to choose from. How well acquainted folks are with all of their options in this sector is another story. Sure, it is safe to&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/-6C4S2Bk-Fo" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 08 Jan 2013 01:52:42 Z</pubDate>
      <a10:updated>2013-01-08T22:25:38Z</a10:updated>
      <author>ETF Professor</author>
      <nasdaq:tickers>FBT</nasdaq:tickers>
      <nasdaq:tickers>FXH</nasdaq:tickers>
      <nasdaq:tickers>PBE</nasdaq:tickers>
      <nasdaq:tickers>PPH</nasdaq:tickers>
      <nasdaq:tickers>VHT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/4-health-care-etfs-your-broker-forgot-to-mention-cm204852</feedburner:origLink></item>
  </channel>
</rss>
